Effects of IMT on Cardiac Resynchronization Therapy
CRT-IMT
EFFECTS OF INSPIRATION MUSCLE TRAINING ON NT-PROBNP, FUNCTIONAL EXERCISE CAPACITY, DAILY LIVING EXERCISE PERFORMANCE, AND QUALITY OF LIFE IN PATIENTS UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
1 other identifier
interventional
32
1 country
1
Brief Summary
Patients who are followed up in the cardiology clinic with a diagnosis of CHF, who have had a CRT implant at least 1 year ago, and who do not receive cardiac rehabilitation will be included. The aim of the study is to investigate the effects of inspiratory muscle training (IMT) on exercise capacity, respiratory muscle strength, NTproBNP and quality of life. Groups Intervention group: Treatment with IMT Control group: Standard care Study hypothesis;
- 1.Does IMT have an effect on exercise capacity and quality of life in patients with CRT?
- 2.Does IMT have an effect on NTproBNP in patients with CRT?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2024
CompletedFirst Submitted
Initial submission to the registry
June 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2025
CompletedFirst Posted
Study publicly available on registry
June 25, 2025
CompletedJuly 18, 2025
June 1, 2025
1.1 years
June 13, 2025
July 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
NT-proBNP
NT-proBNP
enrollment and end of the 12 week treatment
Exercises capacity
Exercise capacity was evaluated using the 6-minute walk test (6MWT). 6MWT was performed according to the ATS/ERS criteria.
enrollment and end of the first week of treatment
Heart rate (Exercises capacity)
Heart rate were measured using a portable pulse oximeter (Cosmed Srl, Cosmed Spiropalm, Rome, Italy), before, after and 1 minute recovery.
enrollment and end of the first week of treatment
Quality of Life of patients
Qality of life was assessed using the Nottingham Health Profile (NHP) self-reported tool. The NHP questionnaire evaluates six dimensions of health (pain, energy level, sleep, physical abilities, emotional reaction and social isolation) and includes 38 items. Total NHP score ranges between 0-600 and quality of life perception is negatively associated with score received
enrollment and end of the 12 week treatment
Secondary Outcomes (2)
Respiratory muscle strength
enrollment and end of the first week of treatment
The performance of patients' activities of daily living
at enrollment and end of the 12 week treatment
Study Arms (2)
İntervention group
EXPERIMENTALinspiratory muscle training
Control group
OTHERStandart care
Interventions
Eligibility Criteria
You may qualify if:
- Patients who were followed up in the cardiology clinic with a diagnosis of CHF,
- CRT implanted at least 1 year ago,
- did not receive cardiac rehabilitation,
- years old,
- communicate in Turkish,
- NYHA II-III
You may not qualify if:
- orthopedic and neurological disorders that may prevent walking,
- acute respiratory tract infection in the last month,
- NYHA I were not included in this study because they were generally not hospitalised and the problems were managed with outpatient diagnosis and treatment, and patients with class IV were not included in this study because they showed severe symptoms for medical and ethical reasons and they were not wanted to be forced with this long-lasting survey application process.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tarsus University
Mersin, Mersin, Turkey (Türkiye)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Doctor who doing ekogardiography.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Phd,PT
Study Record Dates
First Submitted
June 13, 2025
First Posted
June 25, 2025
Study Start
May 15, 2024
Primary Completion
June 15, 2025
Study Completion
June 15, 2025
Last Updated
July 18, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share